Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
65.64
+0.44
+(0.67%)
At close: March 5 at 3:48:53 PM GMT+1
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 1BMRN.MI | -- | -- | -- | -- |
| S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
| Upgrade | Oppenheimer: Perform to Outperform | 2/24/2025 |
| Maintains | Scotiabank: Sector Perform to Sector Perform | 2/20/2025 |
| Maintains | Citigroup: Neutral to Neutral | 2/20/2025 |
| Reiterates | RBC Capital: Sector Perform to Sector Perform | 2/20/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 2/20/2025 |
| Maintains | UBS: Buy to Buy | 2/20/2025 |
Related Tickers
1MRNA.MI Moderna, Inc.
31.98
+7.51%
TRDA Entrada Therapeutics, Inc.
10.42
-1.51%
IPSC Century Therapeutics, Inc.
0.6550
+7.80%
ERAS Erasca, Inc.
1.4200
0.00%
NEXI NexImmune, Inc.
0.0001
-99.93%
LPTX Leap Therapeutics, Inc.
0.4403
+2.61%
LYRA Lyra Therapeutics, Inc.
0.1882
+0.97%
BPTH Bio-Path Holdings, Inc.
0.1725
-0.23%
AIM AIM ImmunoTech Inc.
0.1343
+2.13%
FDMT 4D Molecular Therapeutics, Inc.
4.1400
-0.48%